Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy

  • A Phase II study
  • Riccardo Soffietti, Mauro Nobile, Roberta Rudà, Marzia Borgognone, Alessandra Costanza, Elena Laguzzi, Roberto Mutani
  • Cancer, January 2004, Wiley
  • DOI: 10.1002/cncr.20042

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/cncr.20042

In partnership with: